LOOKS.BO · BSE
LOOKS HEALTH SERVICES LIMITED
₹9.53
-2.85% (-₹0.28)
Prev. close
₹9.81
Volume
6,112
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About LOOKS HEALTH SERVICES LIMITED
Looks Health Services Limited provides dental, and cosmetic and non-cosmetic treatment services in India. The company offers skin treatment, hair transplant, laser transplant, and cosmetic surgery services. It is also involved in the sale of supporting medicine. The company was formerly known as Monarch Health Services Limited and changed its name to Looks Health Services Limited in March 2013. Looks The company was incorporated in 2011 and is based in Ahmedabad, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Ms. Vandanaben Ajeshkumar Sheladiya C.S.
Headquarters
Ahmedabad
Employees
6
Website
looksclinic.inExchange
View on BSE ↗Key stats
Market cap
₹10.01 Cr
P/E ratio (TTM)
476.5
EPS (TTM)
₹0.02
Beta (1Y · daily vs NIFTY 50)
0.14
Beta (5Y · monthly vs NIFTY 50)
0.70
Shares float
79.45 L
EPS · quarter ended Jun 2026
₹0.00
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹75,000 | ₹0 | ₹39.50 L | ₹38.80 L | |
| EBITDA | ₹3.95 L | ₹11.81 L | ₹17.07 L | ₹17.36 L |
| ₹-15.96 L | ₹-1.77 L | ₹2.40 L | ₹2.30 L | |
| Diluted EPS | ₹-0.15 | ₹-0.02 | ₹0.02 | ₹0.02 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹14.88 Cr | ₹14.85 Cr | ₹14.95 Cr | ₹16.11 Cr | |
| ₹0 | ₹0 | ₹0 | — | — | |
| Stockholders' equity | — | ₹14.82 Cr | ₹14.80 Cr | ₹14.83 Cr | ₹14.85 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Current (short-term) debt, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2022-03-31, 2023-03-31, 2024-03-31, 2025-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2022-03-31, 2023-03-31, 2024-03-31, 2025-03-31, 2026-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2026-03-31 has no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹-41.60 L | ₹-34.91 L | ₹-50.49 L | ₹88.51 L | |
| Investing cash flow | ₹44.81 L | ₹26.52 L | ₹72.95 L | ₹-84.74 L |
| Financing cash flow | ₹0 | ₹0 | ₹0 | ₹85.00 L |
| End cash position | ₹16.54 L | ₹8.15 L | ₹30.61 L | ₹1.19 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| LOOKS HEALTH SERVICES LIMITED | ₹10.30 Cr | ₹9.81 | 490.5 | 0.69 | 0.2% | — | -1.7% | +75.5% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 15
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.